DGUOK
Basic information
Region (hg38): 2:73926826-73958961
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (Definitive), mode of inheritance: AR
- portal hypertension, noncirrhotic (Limited), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (Supportive), mode of inheritance: AR
- progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (Supportive), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | AR | Gastrointestinal | In individuals with isolated liver disease, liver transplantation has been described as potentially beneficial, though there has been no reported survival advantage in instances of multisystem illness; Awareness may allow prompt recognition and treatment of manifestations such as neonatal hypoglycemia and hepatic dysfunction | Audiologic/Otolaryngologic; Biochemical; Gastrointestinal; Musculoskeletal; Neurologic | 11687800; 12205643; 15883261; 15887277; 16908739; 18205204; 18825706; 20301766; 21534344; 22137549; 22602837; 22622127; 22868686; 23043144; 23141463; 26874653 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (32 variants)
- Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (11 variants)
- DGUOK-related disorder (2 variants)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Portal hypertension, noncirrhotic, 1 (2 variants)
- Inborn genetic diseases (2 variants)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Portal hypertension, noncirrhotic (1 variants)
- Portal hypertension, noncirrhotic, 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (1 variants)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (1 variants)
- Portal hypertension (1 variants)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DGUOK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 57 | 60 | ||||
missense | 85 | 10 | 107 | |||
nonsense | 11 | |||||
start loss | 3 | |||||
frameshift | 17 | 20 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 2 | 2 | 2 | 16 | 22 | |
non coding | 10 | 61 | 12 | 84 | ||
Total | 34 | 20 | 103 | 128 | 13 |
Highest pathogenic variant AF is 0.0000460
Variants in DGUOK
This is a list of pathogenic ClinVar variants found in the DGUOK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-73926849-C-CAGCG | Mitochondrial DNA depletion syndrome | Uncertain significance (Jun 14, 2016) | ||
2-73926857-C-A | Mitochondrial DNA depletion syndrome | Uncertain significance (Jun 14, 2016) | ||
2-73926861-GGGCGGAAGTGCTCTC-G | Benign (Mar 03, 2015) | |||
2-73926863-G-A | not specified • Mitochondrial DNA depletion syndrome | Benign/Likely benign (Jun 14, 2016) | ||
2-73926890-G-T | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-73926901-C-T | DGUOK-related disorder | Likely benign (Mar 23, 2020) | ||
2-73926903-T-C | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) • DGUOK-related disorder | Uncertain significance (Jan 12, 2018) | ||
2-73926906-G-A | DGUOK-related disorder | Likely benign (Feb 21, 2023) | ||
2-73926906-G-T | Uncertain significance (Jul 22, 2024) | |||
2-73926909-G-T | DGUOK-related disorder | Likely benign (Aug 22, 2023) | ||
2-73926910-G-A | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | Conflicting classifications of pathogenicity (Apr 09, 2024) | ||
2-73926911-A-G | Pathogenic (Jun 03, 2022) | |||
2-73926912-T-C | Pathogenic (Oct 14, 2023) | |||
2-73926913-G-A | Pathogenic (Aug 16, 2023) | |||
2-73926914-G-T | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) • DGUOK-related disorder | Conflicting classifications of pathogenicity (Mar 01, 2024) | ||
2-73926916-C-G | Likely benign (Jul 25, 2023) | |||
2-73926916-C-T | Likely benign (Aug 23, 2023) | |||
2-73926917-G-C | Uncertain significance (May 15, 2019) | |||
2-73926917-G-T | Uncertain significance (Sep 29, 2022) | |||
2-73926918-C-A | Uncertain significance (Jul 20, 2022) | |||
2-73926918-C-G | not specified | Conflicting classifications of pathogenicity (Jul 26, 2022) | ||
2-73926919-G-C | Likely benign (Oct 26, 2023) | |||
2-73926919-G-T | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | Conflicting classifications of pathogenicity (Nov 28, 2022) | ||
2-73926922-CCG-C | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | Likely pathogenic (Mar 26, 2024) | ||
2-73926923-C-T | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) • Inborn genetic diseases | Uncertain significance (Mar 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DGUOK | protein_coding | protein_coding | ENST00000264093 | 7 | 32136 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.71e-7 | 0.584 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.468 | 165 | 149 | 1.11 | 0.00000765 | 1814 |
Missense in Polyphen | 51 | 50.984 | 1.0003 | 640 | ||
Synonymous | -0.503 | 63 | 58.1 | 1.08 | 0.00000292 | 530 |
Loss of Function | 0.989 | 12 | 16.3 | 0.736 | 8.12e-7 | 169 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphorylates deoxyguanosine and deoxyadenosine in the mitochondrial matrix, with the highest efficiency for deoxyguanosine. In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on DGUOK and TK2. Phosphorylates certain nucleoside analogs. Widely used as target of antiviral and chemotherapeutic agents. {ECO:0000269|PubMed:11687801, ECO:0000269|PubMed:17073823, ECO:0000269|PubMed:23043144, ECO:0000269|PubMed:8706825}.;
- Disease
- DISEASE: Portal hypertension, non-cirrhotic (NCPH) [MIM:617068]: An autosomal recessive disorder characterized by portal hypertension associated with hepatosplenomegaly, in absence of cirrhosis, extrahepatic diseases, and splanchnic venous thrombosis. Portal hypertension is defined by a portal venous system pressure that is at least 5 mm Hg higher than the pressure in the inferior vena cava. High pressure in the portal venous system leads to shunting of blood through vessels that are poorly suited to carrying large blood volumes, resulting in collateral circulation and splenomegaly. NCPH patients show normal liver function. {ECO:0000269|PubMed:17073823, ECO:0000269|PubMed:26874653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 (PEOB4) [MIM:617070]: A form of progressive external ophthalmoplegia, a mitochondrial myopathy characterized by progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. PEOB4 patients manifest clinically variable features including mitochondrial myopathy with or without progressive external ophthalmoplegia, recurrent rhabdomyolysis, and adult-onset lower motor neuron syndrome with mild cognitive impairment. {ECO:0000269|PubMed:23043144}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Purine metabolism - Homo sapiens (human);Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Purine metabolism;Metabolism of nucleotides;purine deoxyribonucleosides salvage;Purine metabolism;Metabolism;Nucleotide salvage;Purine salvage
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.208
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.0688
- hipred
- N
- hipred_score
- 0.477
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.784
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dguok
- Phenotype
Gene ontology
- Biological process
- protein phosphorylation;guanosine metabolic process;deoxyribonucleoside monophosphate biosynthetic process;nucleotide biosynthetic process;negative regulation of neuron projection development;purine-containing compound salvage;dGTP metabolic process;purine deoxyribonucleoside metabolic process
- Cellular component
- nucleus;cytoplasm;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- deoxyguanosine kinase activity;ATP binding;deoxynucleoside kinase activity;nucleoside kinase activity